Session 1
Chair: Dr Nicholas Davies, Chair Advisory Scientific Panel, Encephalitis International; Chelsea and Westminster, Charing Cross, and the Royal, Marsden Hospitals, London, UK
09:05 Basic clinical overview to infectious encephalitis
Prof Benedict Michael, University of Liverpool & The Walton Center, Liverpool, UK
09:35 Basic clinical overview to autoimmune encephalitis
Prof Sarosh Irani, Mayo Clinic Florida & University of Oxford
10:05 BREAK
Session 2:
Chair: Assoc Prof Kiran Thakur, Columbia University Irving Medical Center, USA
10:25 Clinical Case Panel
11.25 LUNCH
Session 3:
13:15 How to get your grant/fellowship
Assoc Prof Deanna Saylor, Johns Hopkins University School of Medicine, USA & University Teaching Hospital and the University of Zambia School of Medicine, Lusaka, Zambia
Dr Mashina Chomba, University Teaching Hospital – Adult Hospital, Lusaka, Zambia
Dr Saif Huda Walton Centre Foundation Trust & University of Liverpool, UK
14:00 BREAK
Session 4:
Chairs: Prof Michael Wilson, UCSF Weill Institute for Neurosciences, USA. Dr Sophie Binks, University of Oxford, UK. Dr Thomas Pollak, King’s College London, South London and Maudsley NHS Foundation Trust, UK
14:20 DATABLITZ SESSION
Brain biopsy has a high clinical impact in a selected population of suspected autoimmune encephalitis, while being relatively safe
Dr R.W. van Steenhoven, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
14:30 Human CASPR2 autoantibodies disrupt neuronal network excitability through binding to the CASPR2 shed ectodomain
Ms Débora Serrenho, Centre for Neuroscience and Cell Biology, Coimbra, Portugal
14:40 Pulmonary SARS-CoV-2 infection leads to viral-independent para-infectious immune activation in the brain
Dr Cordelia Dunai, University of Liverpool, UK
14:50 Autoantigen-specific CD4 T cells acquire an exhausted phenotype and persist in patients with antigen-specific autoimmune diseases
Dr Daniela Esser, University Hospital, Schleswig-Holstein
15:00 Clinical, prognostic, and longitudinal functional and neuropsychological features of West Nile virus neuroinvasive disease in the United States: a systematic review and meta[1]analysis
Dr Jackson Roberts, Columbia University , Irving Medical Center, New York, USA
15:10 ExTINGUISH clinical trial in anti-NMDAR encephalitis
Dr Stacey Clardy & Dr Ka-Ho Wong, University of Utah, USA
15:25 BREAK
15:40 Acute symptomatic seizures secondary to autoimmune encephalitis: time to electro[1]clinical seizure freedom
Assist Prof Julien Hébert, University of Toronto &Toronto Western Hospital, Canada
15:50 Prognostic factors for morbidity and mortality outcomes following infectious encephalitis: systematic review and meta-analysis
Dr Thomas Johnson, University Of Oxford, UK
16:00 Serological quantitative, qualitative and functional profiling and neurofilaments as biomarkers in autoimmune encephalitis with LGI1 and CASPR2 antibodies
Dr Pietro Businaro, University of Pavia; Neuroimmunology Research, Section, IRCCS Mondino Foundation, Pavia, Italy
16:10 Extracellular vesicles as a way to prevent neuronal damage in bacterial meningoencephalitis
Dr Miguel Tofiño-Vian, Karolinska Institutet, Stockholn, Sweden
16:20 Diagnostic value of metagenomic next[1]generation sequencing techniques in CNS infections
Dr N.S. Groeneveld & Ms Sabine Olie, Amsterdam UMC, University of Amsterdam, The Netherlands
16:35 Arboviral encephalitis in Pakistan 2017-2020-clinical and laboratory features
and neurological outcomes
Dr Sobia Khan, Aga Khan University, Pakistan
16:35: DRINKS RECEPTION & POSTER VIEWING